Chaga Mushroom and Skin Health: What the Science Shows and Why Biomass Matters
Share
Chaga has been used in Scandinavian and Russian folk medicine for centuries. Modern biochemistry is beginning to explain why. This is what the research shows about how it protects your skin, and why the form it is delivered in matters as much as the ingredient itself.
Inonotus obliquus, known as Chaga, is a parasitic fungus that grows primarily on birch trees in cold northern climates across Siberia, Scandinavia, Canada, and northern parts of the UK. It has been used in traditional medicine for centuries, brewed as a tea and consumed for its broad therapeutic properties. For much of that time, its mechanisms of action were largely unknown. Decades of biochemical research have since identified a remarkable spectrum of bioactive compounds that explain many of its traditional uses.
What makes Chaga particularly relevant to skin health is not any single compound. It is the combination of several distinct mechanisms working simultaneously, targeting the three primary drivers of skin ageing and damage: oxidative stress, UV radiation, and chronic inflammation.
What Chaga actually contains
The bioactive profile of Chaga is unusually dense. Unlike many functional mushrooms that are valued for one or two primary compounds, Chaga contains a broad spectrum of constituents that operate through distinct and complementary pathways.
One of the most powerful antioxidant enzymes in biology. SOD catalyses the conversion of superoxide radicals, among the most destructive free radicals generated by UV exposure and pollution, into hydrogen peroxide and then into harmless water and oxygen. Chaga is among the richest known natural sources of SOD activity.
Chaga's characteristic dark outer layer is composed of a dense melanin complex, largely derived from the birch bark it metabolises. This melanin physically absorbs ultraviolet radiation, intercepting it before it penetrates to living keratinocytes and reducing the expression of matrix metalloproteinases that degrade collagen on UV exposure.
Specifically beta-1,3-1,6 glucans, which exhibit a triple helix tertiary structure responsible for their immune-modulating and anti-inflammatory activity. Beta-glucans stimulate cell renewal, support wound healing, draw deep hydration into the skin barrier, and modulate the immune response from pro-inflammatory toward a more regulated state.
Research published in PubMed Central (PMC10454022) demonstrates that inotodiol and related triterpenoids suppress pro-inflammatory cytokines including IL-1 and IL-6 at a genetic level, reducing the chronic inflammatory cascade that drives collagen matrix breakdown and accelerated skin ageing.
A dense concentration of plant polyphenols that interrupt oxidative stress chain reactions, preserving skin elasticity and firmness. Zhao et al. (2019) demonstrated significant antioxidant and protective effects of Chaga polyphenols on oxidative stress and DNA damage in the Journal of Ethnopharmacology.
Derived from the birch bark Chaga metabolises during growth. Betulinic acid has documented anti-inflammatory and wound-healing properties, with emerging evidence for its role in skin barrier function and cellular repair.
The three mechanisms that protect your skin
1. Neutralising free radicals at the enzymatic level
Every day your skin is exposed to free radicals generated by UV radiation, pollution, and normal cellular metabolism. These unstable molecules steal electrons from skin cells, destroying collagen fibres, breaking down the extracellular matrix, and causing the structural changes visible as wrinkles, loss of elasticity, and uneven tone.
Dietary antioxidants such as Vitamin C and polyphenols work by donating electrons to neutralise free radicals. They are effective, but they are consumed in the process and must be continuously replenished. SOD operates differently. As an enzyme, it catalyses the neutralisation reaction without being consumed, converting superoxide radicals into hydrogen peroxide which is then further processed into water and oxygen by catalase. It works at a speed and scale that no dietary antioxidant can match.
Research examining Chaga's SOD activity using alcohol and hot-water extractions found consistent superoxide dismutase activity across multiple extraction methods. Higher extraction temperatures resulted in stronger antioxidant abilities. An ethanolic extract applied to BJ normal human skin fibroblasts increased SOD1, CAT, and KI67 mRNA expression while decreasing reactive oxygen species production, demonstrating direct protective effects in human skin cells.
Key finding: Chaga extract enhanced the antioxidative stress ability of normal cells, with documented upregulation of antioxidant enzyme expression in human skin fibroblasts.
2. Photoprotection via the melanin complex
Chaga's dark outer sclerotium is one of the most melanin-dense natural substances known. This is not the same melanin produced by human skin in response to UV exposure, but a structurally distinct fungal melanin that functions as a natural UV absorber.
When consumed, the melanin complex contributes to the body's broader antioxidant and photoprotective capacity. Research has demonstrated that Chaga can suppress UV-induced morphological skin changes, including skin thickening and wrinkle formation, and can inhibit the expression of matrix metalloproteinases MMP-1 and MMP-9 in UV-exposed human fibroblasts. These are the enzymes directly responsible for collagen degradation following sun exposure.
Why this matters for collagen: MMP-1 and MMP-9 are the primary collagenases activated by UV radiation. By suppressing their expression, Chaga's melanin complex helps preserve the collagen matrix that gives skin its structural integrity, working upstream of the breakdown process rather than after it has already occurred.
3. Suppressing inflammatory cytokines at a genetic level
Chronic low-grade inflammation is one of the most significant drivers of accelerated skin ageing. When skin is exposed to irritants, UV radiation, or environmental stressors, cells release pro-inflammatory cytokines including IL-1, IL-6, and TNF-alpha. These signalling proteins trigger an inflammatory cascade that, when chronic, degrades connective tissue, reduces skin barrier integrity, and accelerates the visible signs of ageing.
Research published in PubMed Central (PMC10454022) demonstrates that inotodiol and related triterpenoids in Chaga suppress the over-expression of these inflammatory cytokines at the genetic level, reducing the inflammatory environment in skin cells rather than simply masking symptoms. A separate study on atopic dermatitis found that Chaga mushroom extract significantly reduced inflammatory cytokine expression and MAPK marker expression in a murine model, supporting its anti-inflammatory role in skin conditions driven by immune dysregulation.
Why biomass, not extract
The majority of Chaga supplements on the market use an extracted form, either a hot-water extract, an ethanol extract, or a dual-process extract. The argument for extraction is that it concentrates specific compounds and increases their immediate availability. The argument against it, and the reason NDS uses Chaga biomass, is more nuanced and is grounded in the research of Mycology Research Laboratories (MRL), who have studied mushroom biomass since 1997.
- Higher concentration of specific beta-glucans on paper
- Compounds fully exposed to digestive enzymes
- Enzymatic activity largely destroyed in extraction process
- Low levels of secondary metabolites
- Terpenoids, lectins, and metal chelating agents largely absent
- Beta-glucans degraded by pepsin and trypsin before absorption
- Full spectrum of beta-glucans, enzymes, and secondary metabolites
- Physiochemical barriers protect compounds through digestion
- SOD, peroxidase, and cytochrome P-450 enzyme activity preserved
- Higher beta-1,3-1,6 glucan content in the presence of digestive enzymes
- Full secondary metabolite profile including lectins and terpenoids
- Biological response modifier activity intact
The critical distinction identified by MRL research is what happens to extracted versus biomass mushroom compounds in the presence of proteolytic enzymes, the digestive enzymes pepsin and trypsin that break down proteins in the gut. In a study comparing extracted Reishi with Reishi biomass, it was found that in the presence of proteolytic enzymes, the biomass form maintained a significantly higher beta-1,3-1,6 glucan content than the extract. The extraction process removes the physicochemical barriers that protect the active compounds during digestion, leaving them fully exposed to enzymatic degradation before absorption.
MRL's position, developed through research since 1997, is that biomass mushroom products provide three categories of benefit that extracted products cannot replicate: beta-glucans with proteolytic protection, active enzyme content including SOD, peroxidase, and cytochrome P-450, and a full secondary metabolite profile including lectins, terpenoids, antibiotics, and metal-chelating agents.
The key finding: extracted mushroom products do not contain the enzyme fraction. For enzymatic antioxidant activity such as SOD, which is central to Chaga's protective effects on skin cells, the biomass form is the only delivery mechanism that preserves this activity through the digestive tract.
For Chaga specifically, this matters because SOD is an enzyme, not a polyphenol or a polysaccharide. It cannot be standardised into an extract the way a beta-glucan percentage can. The extraction process, whether hot water or ethanol, denatures the protein structure of the enzyme, eliminating its activity. Chaga biomass preserves the full enzymatic profile, including the SOD activity that is central to its antioxidant mechanism in skin cells.
"The question is not how much of a compound is present in the capsule. It is how much survives the digestive tract and reaches the target tissue in active form. Biomass provides physicochemical protection for the full compound spectrum that extraction removes. For enzyme-dependent mechanisms like SOD activity, there is no extracted equivalent."
NDS Clinical Advisory, based on MRL research position
Chaga and collagen: complementary mechanisms
Understanding where Chaga works in relation to collagen makes the clinical rationale for combining the two clearer. They are not doing the same job. They operate at different points in the same biological process.
Chaga works upstream. It neutralises the free radicals that degrade collagen fibres. It absorbs UV radiation before it activates the collagenase enzymes that break down the collagen matrix. It suppresses the inflammatory cytokines that drive chronic connective tissue breakdown. It protects the environment in which collagen synthesis occurs.
Tissue-specific collagen peptides work downstream. CPV 101, the NDS skin and hair peptide, targets fibroblasts directly, binding to receptors and signalling them to increase collagen synthesis. The 10% absorbed intact delivers the biological repair signal. The 90% broken down into proline, glycine, and hydroxyproline supplies the building material.
Chaga reduces the rate of breakdown. Collagen peptides increase the rate of repair and rebuilding. Together they address both sides of the net collagen equation simultaneously.
This is not a theoretical combination. It reflects the clinical logic that skin health outcomes depend on the balance between collagen breakdown and collagen synthesis. Any intervention that only addresses one side of that equation is working at half capacity. Reducing oxidative stress and inflammation while simultaneously signalling fibroblasts to rebuild is a more complete approach than either in isolation.
What the research does and does not show
Intellectual honesty requires being as clear about the gaps as about the evidence. The majority of Chaga research to date has been conducted in vitro or in animal models. Robust, large-scale randomised controlled trials in humans for skin-specific outcomes are limited. The direction of findings across multiple independent research groups is consistent, but the clinical evidence base is not yet at the standard of, for example, the collagen peptide literature.
What can be stated with confidence is that the bioactive compounds in Chaga biomass have well-characterised mechanisms relevant to skin health, that SOD activity is documented across multiple research settings, and that the anti-inflammatory evidence for inotodiol and beta-glucans is supported by published peer-reviewed research.
Frequently asked questions
Why does NDS use biomass rather than an extract?
The biomass form preserves the full compound spectrum, including the enzyme fraction containing SOD, which is central to Chaga's antioxidant mechanism. Extraction destroys enzyme activity. Based on MRL research, biomass also maintains higher beta-glucan content in the presence of digestive enzymes than extracted equivalents, because the physicochemical structure of the biomass protects the compounds during digestion in a way that stripped extracts cannot.
Can I take Chaga biomass alongside collagen peptides?
Yes, and there is a clear clinical rationale for doing so. Chaga addresses the environmental and inflammatory factors that accelerate collagen breakdown. Tissue-specific collagen peptides signal fibroblasts to rebuild and supply the amino acid building blocks to do so. The two mechanisms are complementary rather than overlapping.
How long before skin benefits would be expected?
Functional mushroom supplementation, like collagen peptide supplementation, is a cumulative process rather than an acute one. The antioxidant and anti-inflammatory mechanisms operate continuously from the point of supplementation, but measurable changes in skin texture, elasticity, or appearance are typically reported over weeks to months of consistent daily use.
Is Chaga biomass suitable for daily use?
Based on current research, Chaga biomass is generally considered safe for daily use in healthy adults. As with any supplement, those taking immunosuppressant medications or with autoimmune conditions should discuss with a healthcare practitioner before starting, given Chaga's documented immune-modulating activity.
NDS Chaga uses full-spectrum biomass, not extract, preserving the complete enzyme, beta-glucan, and secondary metabolite profile. Combined with NDS tissue-specific collagen peptides for a complete skin health protocol addressing both protection and rebuilding.
Explore the NDS Range →Sources: PMC10454022 (Chaga inotodiol and inflammatory cytokines); Hu et al. (2009) SOD activity in Chaga extracts; Zhao F. et al. (2019) Journal of Ethnopharmacology; PMC10728660 Frontiers in Pharmacology Chaga review; PMC12861731 atopic dermatitis Chaga study; Mycology Research Laboratories (MRL) biomass vs extract research position (mrlusa.com); Om Mushroom Superfood polysaccharide biomass research summary; Oesser S. (2020) NDS collagen peptide RCT.